Maintenance of blood pressure control and left ventricular performance with small doses of enalapril
- PMID: 10080425
- DOI: 10.1016/s0002-9149(98)00977-1
Maintenance of blood pressure control and left ventricular performance with small doses of enalapril
Abstract
Enalopril treatment (20 mg every 12 hours) of 24 patients with essential hypertension and left ventricular (LV) hypertrophy established normal blood pressure (BP) after 8 weeks, and after 7 years had reduced LV mass index by 39% from 148 +/- 34 to 90 +/- 16 g/m2, and had normalized LV structure and function and QT dispersion. Stepwise reduction of the enalapril dosage from 40 to 30, 20, 10, and 5 mg/day during the eighth year caused no significant changes in BP, LV structure, LV systolic function, or QT dispersion, which all likewise remained unaltered during a further year of the 5-mg/day regimen. We conclude that for hypertensive patients in whom prolonged treatment with standard doses of enalapril has normalized BP, LV structure and function, and QT dispersion, significantly smaller doses are sufficient to maintain these cardiovascular achievements.
Similar articles
-
Step-down of enalapril treatment for arterial hypertension.Hypertension. 1999 Dec;34(6):1287-92. doi: 10.1161/01.hyp.34.6.1287. Hypertension. 1999. PMID: 10601132 Clinical Trial.
-
Reduction of QT and QTc dispersion during long-term treatment of systemic hypertension with enalapril.Am J Cardiol. 1998 Jan 15;81(2):170-4. doi: 10.1016/s0002-9149(97)00869-2. Am J Cardiol. 1998. PMID: 9591900
-
Long-term effects of losartan and enalapril, alone or with a diuretic, on ambulatory blood pressure and cardiac performance in hypertension: a case-control study.Blood Press Monit. 2000 Jun;5(3):187-93. doi: 10.1097/00126097-200006000-00008. Blood Press Monit. 2000. PMID: 10915233 Clinical Trial.
-
Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.Minerva Cardioangiol. 2002 Jun;50(3):169-74. Minerva Cardioangiol. 2002. PMID: 12107398 Review.
-
Changes in left ventricular geometry during antihypertensive treatment.Pharmacol Res. 2018 Aug;134:193-199. doi: 10.1016/j.phrs.2018.06.026. Epub 2018 Jun 26. Pharmacol Res. 2018. PMID: 29959031 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical